Literature DB >> 18440283

Emotional and state-dependent modification of cardiorespiratory function: role of orexinergic neurons.

Tomoyuki Kuwaki1, Wei Zhang, Akira Nakamura, Ben-Shiang Deng.   

Abstract

Our daily life not only involves calm, resting states but is filled with perturbations that induce active conditions, such as movements, eating, and communicating. During such active periods, cardiorespiratory regulation must be adjusted for bodily demands, which differ from those during resting states, by modulating or resetting baseline levels. To explore neural mechanisms of state-dependent adjustments of central autonomic regulation, we recently focused on the following two states: 1), stress-induced defense (fight-or-flight) responses, because stressors induce both cognitive, emotional, and behavioral changes and autonomic alterations, and 2), sleep/wake differences. Basal respiration and respiratory reflex regulation significantly differ during waking and sleep states. In this review, we will summarize our recent findings with orexin knockout and orexin neuron-ablated mice to determine possible contributions of orexin, a hypothalamic neuropeptide, to state-dependent adjustments of central autonomic regulation. The diversity of synaptic control of cardiovascular and respiratory neurons appears to be necessary for animals to adapt to ever-changing life circumstances and behavioral states. The orexin system likely functions as one essential modulator for coordinating circuits controlling autonomic functions and behaviors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440283     DOI: 10.1016/j.autneu.2008.03.004

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  20 in total

1.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

Review 2.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 3.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

4.  The orexinergic neurons receive synaptic input from C1 cells in rats.

Authors:  Genrieta Bochorishvili; Thanh Nguyen; Melissa B Coates; Kenneth E Viar; Ruth L Stornetta; Patrice G Guyenet
Journal:  J Comp Neurol       Date:  2014-07-14       Impact factor: 3.215

5.  The orexin receptor 1 (OX1R) in the rostral medullary raphe contributes to the hypercapnic chemoreflex in wakefulness, during the active period of the diurnal cycle.

Authors:  Mirela Barros Dias; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2009-12-06       Impact factor: 1.931

Review 6.  Central respiratory chemoreception.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Douglas A Bayliss
Journal:  J Comp Neurol       Date:  2010-10-01       Impact factor: 3.215

Review 7.  Retrotrapezoid nucleus and parafacial respiratory group.

Authors:  Patrice G Guyenet; Daniel K Mulkey
Journal:  Respir Physiol Neurobiol       Date:  2010-02-25       Impact factor: 1.931

8.  Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.

Authors:  Philip L Johnson; Brian C Samuels; Stephanie D Fitz; Stafford L Lightman; Christopher A Lowry; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2012-03-28       Impact factor: 7.853

9.  An augmented CO2 chemoreflex and overactive orexin system are linked with hypertension in young and adult spontaneously hypertensive rats.

Authors:  Aihua Li; Sarah H Roy; Eugene E Nattie
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

10.  Activation of the retrotrapezoid nucleus by posterior hypothalamic stimulation.

Authors:  Michal G Fortuna; Ruth L Stornetta; Gavin H West; Patrice G Guyenet
Journal:  J Physiol       Date:  2009-09-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.